The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor infiltrating lymphocytes (TILs) in endometrioid and clear cell ovarian carcinoma: Characterization, association with mismatch repair system deficiency and endometriosis, and prognostic implications.
 
Alejandro Gallego
Consulting or Advisory Role - Clovis Oncology; GlaxoSmithKline; PharmaMar
Speakers' Bureau - AstraZeneca; Clovis Oncology; MSD; Roche
Travel, Accommodations, Expenses - MSD; Pfizer; PharmaMar; Pierre Fabre; Roche; Tesaro/GSK
 
Alberto Berjon
No Relationships to Disclose
 
Marta Mendiola
Speakers' Bureau - GlaxoSmithKline
Research Funding - Eisai
Travel, Accommodations, Expenses - Pfizer; PharmaMar
 
Jesus Diez
No Relationships to Disclose
 
Beatriz Castelo
No Relationships to Disclose
 
Alicia Hernandez
No Relationships to Disclose
 
David Hardisson
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Agilent
 
Jaime Feliu Batlle
Consulting or Advisory Role - Amgen; Baxter; Eisai; Ipsen; Merck; Novartis; Roche; Sirtex Medical
Research Funding - Amgen; Merck
Travel, Accommodations, Expenses - Servier/Pfizer
 
Maria Jose Garcia
No Relationships to Disclose
 
Andrés Redondo
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Research Funding - Eisai (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar